Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
mPAC-L20 |
Mouse pancreatic duct cells | Mouse | digestive organs | unknown | siRNA | RNA-Interference | Metafectene SI | publication | M. Ejarque et al., J. Biol. Chem., Apr 2013; 288: 11705 - 11717 | Link | |||
mIMCD3 |
Mouse kidney inner medullary collecting duct (IMCD) cell line | ATCC CRL-2123 | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Hatem-Vaquero et al., BBA - Gene Regulatory Mechanisms, 2017, 1860: 922-935 | ||
mIMCD3 |
Mouse inner medullary collecting duct cells | ATCC CRL-2123 | Mouse | urinary system | cell line | adherent | miRNA | Metafectene SI | publication | K. Kang et al., Am J Physiol Cell Physiol, 2021, 320: C225–C239, doi:10.1152/ajpcell.00441.2020 | Link | ||
mIMCD3 |
Mouse kidney inner medullary collecting duct (IMCD) cell line | ATCC CRL-2123 | Mouse | urinary system | cell line | adherent | miRNA | Metafectene SI | publication | K. Kang et al., Am. J. Physiol. Cell Physio., 2021, 320: C225–C239, doi:10.1152/ajpcell.00441.2020 | Link | ||
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., SpringerPlus, 2016, 5:156; DOI 10.1186/s40064-016-1768-6 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | J.-E. Lee et al., Journal of Proteomics, 2016, 131: 17-28; doi.org/10.1016/j.jprot.2015.10.005 | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | miRNA | Metafectene SI | application note | ![]() |
|||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. De Luca et al., Scientific Reports, 2021, 11: 4615, doi.org/10.1038/s41598-021-84222- | Link | |
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link | ||
M14 |
Human metastatic melanoma cells | Human | skin | cell line | adherent | plasmid | CRISPR | Metafectene SI | publication | A. Sarma et al., The American J. of Pathology, 2021, 191, 2, doi.org/10.1016/j.ajpath.2020.10.015 | Link | ||
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob-Schwarzl et al., Oncotarget, 2017, 8(60): 101224-101243 | Link | |
Hs888 |
Human osteosarcoma cell line | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., J. Cell Commun. Signal., 2015, 9:55-62; DOI 10.1007/s12079-015-0265-y | |||
Hs888 |
Human osteosarcoma cell line | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. L. Vasco et al., J. Cell Commun. Signal, 2014, 8:219-229, DOI 10.1007/s12079-014-0235-9 | Link | ||
Hs888 |
Human osteosarcoma cell line | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., Anticancer Res, Aug 2014; 34: 4069 - 4075 | |||
Hs888 |
Human osteosarcoma cell line | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Leopizzi., PhD Thesis, 2018, University of Rome | Link | ||
hPBMC |
Human primary peripheral blood mononuclear cells | Human | immune system | primary cell | suspension | plasmid | Metafectene SI | publication | S. Smith, PhD Thesis, 2013, Royal College of Surgeons in Ireland | Link | |||
hOMs |
Human primary olfactory mucosal cells | Human | sensory organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Chew et al., Chew et al. Particle and Fibre Toxicology , 2020, 17: 18, doi.org/10.1186/s12989-020-00352-4 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. Prokesch et al., FASEB J., 2017, 31: 732-742 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene SI | application note | ![]() |
|||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | miRNA | Metafectene SI | publication | S. Smith, JCI Insight, 2018, 3(15):e120798, doi.org/10.1172/jci.insight.120798 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | R. Romano et al., Cell. and Mol. Life Sci., 2021, 78: 351–372, 78:351–372, doi.org/10.1007/s00018-020-03510-1 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. M. Giudetti et al., BBA, 2020, 1865, doi.org/10.1016/j.bbalip.2020.158805 | Link |